Multi-omic machine learning predictor of breast cancer therapy response
7 Dec 2021 in Nature, vol. 601, pp. 623–629
DOI: https://doi.org/10.1038/s41586-021-04278-5
Research output: Contribution to Journal › Article (Published)
Accurate Estrogen Receptor Quantification in Patients with Negative and Low-Positive Estrogen-Receptor-Expressing Breast Tumors: Sub-Analyses of Data from Two Clinical Studies
11 Mar 2019 in Advances in Therapy
DOI: https://doi.org/10.1007/s12325-019-0896-0
Research output: Contribution to Journal › Article (Published)
Molecular changes during extended neoadjuvant letrozole treatment of breast cancer: distinguishing acquired resistance from dormant tumours
7 Jan 2019 in Breast Cancer Research, vol. 21
DOI: https://doi.org/10.1186/s13058-018-1089-5
Research output: Contribution to Journal › Article (Published)
Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project
(10 pages) 6 Aug 2018 in European Journal of Cancer, vol. 101, pp. 210-219
DOI: https://doi.org/10.1016/j.ejca.2018.06.027
Research output: Contribution to Journal › Article (Published)
Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ
11 Jan 2018 in European Journal of Surgical Oncology (EJSO), vol. 44, pp. 429-435
DOI: https://doi.org/10.1016/j.ejso.2017.12.007
Research output: Contribution to Journal › Article (Published)